ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

PDQ Needs Change, Advocates Say, NBCC to Build Its Own Trials Registry

October 11, 1996

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

Arizona Cancer Center Convinces State To Set Lower Limits For Aflatoxin

February 23, 1979

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990